Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Stephanie Yohay
Institution:
Medical College of Wisconsin
Observed institution:
Medical College of Wisconsin
ORCID:
0009-0008-9108-177X
Observed ORCID:
0009-0008-9108-177X
OpenAlex ID:
A5111397644
Outcomes of frail patients undergoing high‐dose chemotherapy and autologous stem cell transplantation for multiple myeloma
2024
·
Stephanie Yohay
, Temitope Oloyede
, et al.
·
British Journal of Haematology
·
5
PDF
MEK inhibitor-based therapy in metastatic pancreatic adenocarcinoma with KRAS G12R alteration.
2025
·
Elizabeth Auckley
, Grace Ying
, et al.
·
Journal of Clinical Oncology
·
4
MEK inhibitor–based genomically matched combinatorial targeted therapies in metastatic pancreatic adenocarcinoma with KRAS alterations
2026
·
Elizabeth D Auckley
, Stephanie Yohay
, et al.
·
The Oncologist
·
1
The diagnostic utility of the soluble CD25-to-ferritin ratio in lymphoma-associated hemophagocytic lymphohistiocytosis
2026
·
Dariusz Uczkowski
, Linzi M. Hobbs
, et al.
·
Leukemia Research
The predictive value of the interleukin 2 receptor (IL2)/ferritin ratio in the diagnosis of lymphoma associated hemophagocytic lymphohistiocytosis (LAHS): A United States, multi center experience
2025
·
Dariusz Uczkowski
, Linzi Hobbs-Parker
, et al.
·
Blood
PDF
High tolerability and favorable early outcomes with full-dose lenalidomide in older adults with newly diagnosed multiple myeloma on triplet and quadruplet therapies
2025
·
Stephanie Yohay
, Soyoung Kim
, et al.
·
Blood
Impact of neoadjuvant radiation therapy modalities on post-surgical lymphopenia in operable pancreatic cancer.
2025
·
Soon Khai Low
, Samih Z Thalji
, et al.
·
Journal of Clinical Oncology
PDF
MEK inhibitor-based therapy in metastatic pancreatic adenocarcinoma with KRAS G12D or KRAS G12V alteration.
2025
·
Stephanie Yohay
, Grace Ying
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
8
Citation count:
10
H-index:
2
I10-index:
Year
Topic
Type